For men in the United States, prostate cancer is not only the most common cancer but also the second leading cause of cancer-associated death. Advanced prostate cancer can metastasize to several different organ systems including the lymph nodes, bones, lungs, and visceral organs. Prognosis for metastatic prostate cancer is poor with the relative 5-year survival rate being about 28%.1 We present a case of metastatic prostate cancer in complete remission after androgen deprivation, surgery, androgen receptor blockade, and Radium 223 therapy.
Urology case reports. 2018 Sep 19*** epublish ***
Authors: Olamide O Omidele, Howard I Schiff, William Oh, Ashutosh Tewari
Reference:
1. Society A.C. 2013. Cancer Facts and Figures 2013.
Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Department of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.